X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (122) 122
monobactams - therapeutic use (66) 66
aztreonam - therapeutic use (50) 50
anti-bacterial agents - therapeutic use (44) 44
monobactams - pharmacology (44) 44
pharmacology & pharmacy (41) 41
male (39) 39
female (35) 35
anti-bacterial agents - pharmacology (31) 31
bacterial infections - drug therapy (31) 31
index medicus (30) 30
microbial sensitivity tests (29) 29
antibiotics (27) 27
cephalosporins - therapeutic use (27) 27
infectious diseases (27) 27
middle aged (26) 26
adult (25) 25
monobactams (25) 25
aztreonam (24) 24
cephalosporins - pharmacology (24) 24
microbiology (23) 23
monobactam (21) 21
aged (19) 19
clinical trials as topic (18) 18
infections (18) 18
animals (17) 17
anti-bacterial agents - administration & dosage (17) 17
drug resistance, microbial (17) 17
aztreonam - pharmacology (16) 16
carbapenems - therapeutic use (16) 16
cephalosporins (16) 16
penicillins - therapeutic use (16) 16
urinary tract infections - drug therapy (16) 16
gram-negative bacteria (14) 14
pseudomonas-aeruginosa (13) 13
adolescent (12) 12
anti-bacterial agents - adverse effects (12) 12
beta-lactam antibiotics (12) 12
monobactams - administration & dosage (12) 12
aztreonam - adverse effects (11) 11
carbapenems - pharmacology (11) 11
immunology (11) 11
penicillin (11) 11
pneumonia - drug therapy (11) 11
treatment outcome (11) 11
beta-lactam (10) 10
beta-lactamase inhibitors (10) 10
gram-negative bacterial infections - drug therapy (10) 10
oncology (10) 10
penicillins - pharmacology (10) 10
skin tests (10) 10
aminoglycosides (9) 9
aminoglycosides - therapeutic use (9) 9
aztreonam - administration & dosage (9) 9
dosage (9) 9
penicillins - adverse effects (9) 9
pseudomonas aeruginosa - drug effects (9) 9
thienamycins - therapeutic use (9) 9
aged, 80 and over (8) 8
aztreonam - pharmacokinetics (8) 8
carbapenem (8) 8
child (8) 8
cross-reactivity (8) 8
escherichia coli - drug effects (8) 8
gram-negative bacteria - drug effects (8) 8
monobactams - chemistry (8) 8
pathogens (8) 8
pseudomonas infections - drug therapy (8) 8
resistance (8) 8
allergy (7) 7
aztreonam: new developments and current perspectives (7) 7
bacteria (7) 7
bacteria - drug effects (7) 7
beta-lactams - adverse effects (7) 7
beta-lactams - therapeutic use (7) 7
carbapenems (7) 7
cephalosporins - adverse effects (7) 7
chemistry (7) 7
chemistry, medicinal (7) 7
cross infection - drug therapy (7) 7
cross reactions (7) 7
drug hypersensitivity - diagnosis (7) 7
drug therapy, combination (7) 7
escherichia-coli (7) 7
monobactams - adverse effects (7) 7
structure-activity relationship (7) 7
time factors (7) 7
beta-lactamases - metabolism (6) 6
carbapenems - adverse effects (6) 6
ceftazidime (6) 6
ceftazidime - therapeutic use (6) 6
cephalosporin (6) 6
child, preschool (6) 6
gram-negative infections (6) 6
internal medicine (6) 6
klebsiella pneumoniae - drug effects (6) 6
klebsiella-pneumoniae (6) 6
medical cures (6) 6
medicine & public health (6) 6
penicillin resistance (6) 6
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (138) 138
French (3) 3
Russian (3) 3
Spanish (3) 3
German (1) 1
Japanese (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 833 - 838
Journal Article
Critical Care, ISSN 1364-8535, 07/2017, Volume 21, Issue 1, pp. 180 - 8
Background: Antibiotics are commonly administered to hospitalized patients with infiltrates for possible bacterial pneumonia, often leading to unnecessary... 
De-escalation | Pneumonia | Antibiotics | Mechanical ventilation | MORTALITY | INFECTIONS | CRITICALLY-ILL | PREVALENCE | CRITICAL CARE MEDICINE | Prospective Studies | Cefepime | Monobactams - analysis | Humans | Middle Aged | Ceftriaxone - pharmacology | Male | Cephalosporins - analysis | Quinolones - pharmacology | Monobactams - therapeutic use | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Carbapenems - pharmacology | Respiration, Artificial - adverse effects | Quinolones - analysis | Quinolones - therapeutic use | Statistics, Nonparametric | Female | Cephalosporins - pharmacology | Pneumonia, Ventilator-Associated - drug therapy | Anti-Bacterial Agents - analysis | Hospital Mortality | Carbapenems - analysis | Intensive Care Units - organization & administration | Cross-Over Studies | Ceftriaxone - analysis | Ceftriaxone - therapeutic use | Pneumonia - drug therapy | Carbapenems - therapeutic use | Aged | Anti-Bacterial Agents - pharmacology | Academic Medical Centers - organization & administration | Monobactams - pharmacology | Hospital patients | Drug resistance in microorganisms | Medical research | Bacterial pneumonia | Mortality | Medicine, Experimental | Drug therapy | Pharmacists | Pathogens | Intensive care | Decision making | Critical care | Antimicrobial agents | Infections | Drug resistance | Clinical outcomes | Infectious diseases | Hospitals | Teams | Sepsis | Bacteria | Adults
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 04/2017, Volume 60, Issue 7, pp. 2669 - 2684
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2001, Volume 32, Issue 3, pp. 402 - 412
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 10/2011, Volume 9, Issue 10, pp. 909 - 922
The spread of resistance among Gram-positive and Gram-negative bacteria represents a growing challenge for the development of new antimicrobials. The pace of... 
ESBL | new classes of antimicrobials | new anti-Gram-negative compounds | MBL | ESCAPE | BACTERIA | ESCHERICHIA-COLI | CARBAPENEM | CEFTAZIDIME PLUS | COMPLICATED SKIN | PSEUDOMONAS-AERUGINOSA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | BETA-LACTAMASE INHIBITOR | CEFTAROLINE | IN-VITRO ACTIVITY | Polymyxins - therapeutic use | Carbapenems - administration & dosage | Humans | beta-Lactamases - administration & dosage | Monobactams - administration & dosage | Antimicrobial Cationic Peptides - administration & dosage | Protein Synthesis Inhibitors - administration & dosage | Indoles - administration & dosage | Monobactams - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Infection Control - organization & administration | Aminoglycosides - administration & dosage | Gram-Negative Bacteria - physiology | Drug Resistance, Multiple, Bacterial - physiology | Drug Administration Schedule | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | beta-Lactamases - therapeutic use | Drug Discovery | Antimicrobial Cationic Peptides - therapeutic use | Gram-Negative Bacteria - drug effects | Polymyxins - administration & dosage | Carbapenems - therapeutic use | Gram-Negative Bacteria - pathogenicity | Indoles - therapeutic use | Anti-Bacterial Agents - administration & dosage | Drug Resistance, Multiple, Bacterial - drug effects | Protein Synthesis Inhibitors - therapeutic use | Aminoglycosides - therapeutic use | Usage | Care and treatment | Anti-infective agents | Beta lactamases | Product development | Gram-negative bacteria | Health aspects | Outer membranes | Antimicrobial agents | Protein biosynthesis | Drug development | Tides | Infection | Ribosomal subunits | Reviews | Antibiotics | Cephalosporins | Developmental stages | Tetracyclines | Antimicrobial peptides | Keys | Aminoglycoside antibiotics | Carbapenems | Polymyxins
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2010, Volume 107, Issue 51, pp. 22002 - 22007
Journal Article
Journal Article
Przegla̧d epidemiologiczny, ISSN 0033-2100, 2013, Volume 67, Issue 1, pp. 51 - 140
To obtain a status of a medicinal product, a compound possessing potential antimicrobial activity and displaying no cytotoxicity, must undergo three phases of... 
Cephalosporins - therapeutic use | Pregnancy | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Humans | Drugs, Investigational - therapeutic use | Female | Male | Drug Resistance, Bacterial - drug effects | beta-Lactamase Inhibitors | Monobactams - therapeutic use
Journal Article
Journal Article